Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Pacira BioSciences, Inc.Financial_Report.xls
10-Q - 10-Q - Pacira BioSciences, Inc.a12-8876_110q.htm
EX-31.2 - EX-31.2 - Pacira BioSciences, Inc.a12-8876_1ex31d2.htm
EX-10.1 - EX-10.1 - Pacira BioSciences, Inc.a12-8876_1ex10d1.htm
EX-10.3 - EX-10.3 - Pacira BioSciences, Inc.a12-8876_1ex10d3.htm
EX-32.1 - EX-32.1 - Pacira BioSciences, Inc.a12-8876_1ex32d1.htm
EX-31.1 - EX-31.1 - Pacira BioSciences, Inc.a12-8876_1ex31d1.htm
EX-10.2 - EX-10.2 - Pacira BioSciences, Inc.a12-8876_1ex10d2.htm
EX-10.4 - EX-10.4 - Pacira BioSciences, Inc.a12-8876_1ex10d4.htm

Exhibit 32.2

 

STATEMENT PURSUANT TO 18 U.S.C. §1350

 

Pursuant to 18 U.S.C. §1350, the undersigned certifies that this Quarterly Report on Form 10-Q of Pacira Pharmaceuticals, Inc. for the quarter ended March 31, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Pacira Pharmaceuticals, Inc.

 

Date: May 9, 2012

/s/ James Scibetta

 

James Scibetta

 

Chief Financial Officer

 

(Principal Financial Officer)